Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Merck & Co (MRK.US)$$Pfizer (PFE.US)$$BioNTech (BNTX.US)$$A...

$Merck & Co (MRK.US)$ $Pfizer (PFE.US)$ $BioNTech (BNTX.US)$ $ASTRAZENECA PLC (AZNCF.US)$ $Moderna (MRNA.US)$ Dr. Scott Gottlieb explained why he’s optimistic about Merck’s Covid antiviral pill after the drugmaker asked the Food and Drug Administration Monday to authorize its pill to treat people with mild to moderate Covid symptoms.
“The topline data from this Merck study was probably the best treatment effect we’ve seen from orally available antiviral drug in the treatment of any respiratory pathogen, so this can make a real difference,” said the former FDA chief in the Trump administration.
If the agency signs off on the drug, it will be the first pill shown to work against Covid-19 and Americans could get it by the end of the year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
6
+0
1
Translate
Report
72K Views
Comment
Sign in to post a comment
313Followers
7Following
430Visitors
Follow